This is a preview of subscription content, log in to check access.
Berhane S, Toyoda H, Tada T, Kumada T et al (2016) Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients. Clin Gastroenterol Hepatol 14:875–886CrossRefGoogle Scholar
Sturgeon CM, Duffy MJ, Hofmann BR et al (2010) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 56:e1–e48CrossRefPubMedPubMedCentralGoogle Scholar